bendamustine hydrochloride has been researched along with Cancer of Ovary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eulitt, P; Fabian, D; Hemminger, J; Kelly, C; William, BM | 1 |
| Alberts, DS; Baker, AF; Chambers, SK; Clouser, MC; Cohen, JL; Cui, H; Laughren, C; Roe, DJ; Wright, HM | 1 |
| Doll, K; Harstrick, A; Hoffmann, B; Seeber, S; Strumberg, D | 1 |
1 trial(s) available for bendamustine hydrochloride and Cancer of Ovary
| Article | Year |
|---|---|
Investigation of bendamustine HCL in a phase 2 study in women with resistant ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Biomarkers, Tumor; Female; Humans; Keratin-18; Middle Aged; Nitrogen Mustard Compounds; Ovarian Neoplasms; Treatment Outcome | 2013 |
2 other study(ies) available for bendamustine hydrochloride and Cancer of Ovary
| Article | Year |
|---|---|
Waldenström's macroglobulinemia masquerading as ovarian cancer with peritoneal carcinomatosis, ascites, and elevated CA-125.
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Bendamustine Hydrochloride; CA-125 Antigen; Female; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Rituximab; Waldenstrom Macroglobulinemia | 2019 |
Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Breast Neoplasms; Carmustine; Cisplatin; Cyclophosphamide; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Melphalan; Nitrogen Mustard Compounds; Ovarian Neoplasms; Tumor Cells, Cultured | 1996 |